Stay updated with breaking news from General Oral Solid Dosage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hyderabad, Telangana, India Revenue grows 42% in Q1FY23. Pharma Revenue in Latin America up 39%. Profit After Tax up 32% YoY. Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the first quarter of financial year
Hyderabad (Telangana) [India], August 3 (ANI/NewsVoir): Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the first quarter of financial year 2023 ended June 30, 2022. Financial Highlights: Quarterly Financial Results for Quarter ending 30.6.22 are not strictly comparable with Quarter ending 30.6.21 due to the consolidation of Balaxi Healthcare LDA Angola (BHA) which became a wholly owned subsidiary of Balaxi Global DMCC with effect from 1st January 2022. Revenue: The strong growth in revenue of 41.9 per cen...
Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the quarter and full-ye